Bicycle Therapeutics Plc (BCYC)
3.38
-0.18
(-5.06%)
USD |
NASDAQ |
Oct 02, 16:00
3.38
0.00 (0.00%)
After-Hours: 20:00
Bicycle Therapeutics Profit Margin (Quarterly) : -8.00K% for June 30, 2026
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -8.00K% |
| March 31, 2026 | -6.86K% |
| December 31, 2025 | -42.03% |
| September 30, 2025 | -503.7% |
| June 30, 2025 | -2.70K% |
| March 31, 2025 | -608.9% |
| December 31, 2024 | -1.40K% |
| September 30, 2024 | -1.90K% |
| June 30, 2024 | -425.3% |
| March 31, 2024 | -136.0% |
| December 31, 2023 | -921.0% |
| September 30, 2023 | -932.3% |
| June 30, 2023 | -373.8% |
| March 31, 2023 | -797.9% |
| December 31, 2022 | -941.2% |
| September 30, 2022 | -932.5% |
| June 30, 2022 | -612.8% |
| March 31, 2022 | -714.1% |
| Date | Value |
|---|---|
| December 31, 2021 | -478.3% |
| September 30, 2021 | -338.8% |
| June 30, 2021 | -1.00K% |
| March 31, 2021 | -895.5% |
| December 31, 2020 | -453.0% |
| September 30, 2020 | -263.9% |
| June 30, 2020 | -771.2% |
| March 31, 2020 | -1.00K% |
| December 31, 2019 | -83.43% |
| September 30, 2019 | -1.54K% |
| June 30, 2019 | -671.3% |
| March 31, 2019 | -101.9% |
| December 31, 2018 | -753.5% |
| September 30, 2018 | -477.8% |
| June 30, 2018 | -299.8% |
| March 31, 2018 | -90.24% |
| December 31, 2017 | -975.6% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Autolus Therapeutics Plc | -85.60% |
| Akari Therapeutics Plc | -- |
| Cellectis SA | -417.3% |
| DBV Technologies SA | -- |
| Oxford Biomedica Plc | -- |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -32.07% |
| Return on Assets | -26.59% |
| Return on Invested Capital | -31.40% |
| Gross Profit Margin (Quarterly) | -69.64% |
| Operating Margin (Quarterly) | -9.71K% |
| Return on Net Operating Assets | -1.10K% |